These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 17622118

  • 1. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.
    Na DH, Lee JE, Jang SW, Lee KC.
    AAPS PharmSciTech; 2007 Jun 08; 8(2):Article 43. PubMed ID: 17622118
    [Abstract] [Full Text] [Related]

  • 2. Effect of PEGylation on stability of peptide in poly(lactide-co-glycolide) microspheres.
    Park EJ, Tak TH, Na DH, Lee KC.
    Arch Pharm Res; 2010 Jul 08; 33(7):1111-6. PubMed ID: 20661722
    [Abstract] [Full Text] [Related]

  • 3. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G, Qiu W, DeLuca PP.
    Pharm Res; 2003 Mar 08; 20(3):452-9. PubMed ID: 12669968
    [Abstract] [Full Text] [Related]

  • 4. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L, Cheng J, Chi Q, Qie J, Liu Y, Mei X.
    Chem Pharm Bull (Tokyo); 2006 Sep 08; 54(9):1259-65. PubMed ID: 16946531
    [Abstract] [Full Text] [Related]

  • 5. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE.
    Pharm Res; 2012 Jan 08; 29(1):110-20. PubMed ID: 21744173
    [Abstract] [Full Text] [Related]

  • 6. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH, DeLuca PP.
    Pharm Res; 2005 May 08; 22(5):736-42. PubMed ID: 15906168
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.
    Na DH, Youn YS, Lee SD, Son MW, Kim WB, DeLuca PP, Lee KC.
    J Control Release; 2003 Oct 30; 92(3):291-9. PubMed ID: 14568410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B, Mäder K, Kroll C, Borchert HH, Kissel T.
    J Control Release; 1999 May 01; 59(1):23-32. PubMed ID: 10210719
    [Abstract] [Full Text] [Related]

  • 10. In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres.
    Park EJ, Na DH, Lee KC.
    Int J Pharm; 2007 Oct 01; 343(1-2):281-3. PubMed ID: 17644286
    [Abstract] [Full Text] [Related]

  • 11. In-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment.
    Du L, Mei X, Wang C, Li X, Zhang F, Jin Y.
    Anticancer Drugs; 2011 Mar 01; 22(3):262-72. PubMed ID: 21360849
    [Abstract] [Full Text] [Related]

  • 12. A novel in vitro release technique for peptide containing biodegradable microspheres.
    Kostanski JW, DeLuca PP.
    AAPS PharmSciTech; 2000 Mar 09; 1(1):E4. PubMed ID: 14727853
    [Abstract] [Full Text] [Related]

  • 13. Peptide acylation by poly(alpha-hydroxy esters).
    Lucke A, Kiermaier J, Göpferich A.
    Pharm Res; 2002 Feb 09; 19(2):175-81. PubMed ID: 11883645
    [Abstract] [Full Text] [Related]

  • 14. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP.
    J Control Release; 1999 Aug 05; 60(2-3):279-86. PubMed ID: 10425333
    [Abstract] [Full Text] [Related]

  • 15. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
    Selmin F, Blasi P, DeLuca PP.
    AAPS PharmSciTech; 2012 Dec 05; 13(4):1465-72. PubMed ID: 23090111
    [Abstract] [Full Text] [Related]

  • 16. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK, Lawter JR, Huang WJ, Pankey SC, Nightlinger NS, Lynch DH, Schuh JA, Morrissey PJ, Gombotz WR.
    Pharm Res; 1997 Oct 05; 14(10):1422-30. PubMed ID: 9358556
    [Abstract] [Full Text] [Related]

  • 17. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D, Alonso MJ.
    Eur J Pharm Biopharm; 1998 May 05; 45(3):285-94. PubMed ID: 9653633
    [Abstract] [Full Text] [Related]

  • 18. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM, Kim SW.
    Pharm Res; 2004 Feb 05; 21(2):339-43. PubMed ID: 15032317
    [Abstract] [Full Text] [Related]

  • 19. Functionality-type and chemical-composition separation of poly(lactide-co-glycolide) using gradient elution normal-phase liquid chromatography with basic and acidic additives.
    Serizawa M, Reekers J, van Delft P, van Bruijnsvoort M, Schoenmakers PJ, Gargano AFG.
    J Chromatogr A; 2024 Aug 16; 1730():465137. PubMed ID: 38996514
    [Abstract] [Full Text] [Related]

  • 20. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
    Mallardé D, Boutignon F, Moine F, Barré E, David S, Touchet H, Ferruti P, Deghenghi R.
    Int J Pharm; 2003 Aug 11; 261(1-2):69-80. PubMed ID: 12878396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.